Reaction
Breakthrough Haemolysis reporting signals
As of the last recalculation, Breakthrough Haemolysis appears in 376 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is RAVULIZUMAB (PRR 1,190.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ravulizumab | 164 | 1,190.7 | 1,205.4 |
| Eculizumab | 140 | 226.6 | 227.2 |